Last updated on August 2019

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of MT-5199 administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.

Clinical Study Identifier: NCT03176771

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.